The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan
Open accessAbstract
Vaccines are effective interventions that can reduce the high burden of diseases globally. However, public vaccine hesitancy is a pressing problem for public health authorities. With the availability of COVID-19 vaccines, little information is available on the public acceptability and attitudes towards the COVID-19 vaccines in Jordan. This study aimed to investigate the acceptability of COVID-19 vaccines and its predictors in addition to the attitudes towards these vaccines among public in Jordan. An online, cross-sectional, and self-administered questionnaire was instrumentalized to survey adult participants from Jordan on the acceptability of COVID-19 vaccines. Logistic regression analysis was used to find the predictors of COVID-19 vaccines’ acceptability. A total of 3,100 participants completed the survey. The public acceptability of COVID-19 vaccines was fairly low (37.4%) in Jordan. Males (OR = 2.488, 95CI% = 1.834–3.375, p < .001) and those who took the seasonal influenza vaccine (OR = 2.036, 95CI% = 1.306–3.174, p = .002) were more likely to accept COVID-19 vaccines. Similarly, participants who believed that vaccines are generally safe (OR = 9.258, 95CI% = 6.020–14.237, p < .001) and those who were willing to pay for vaccines (OR = 19.223, 95CI% = 13.665–27.042, p < .001), once available, were more likely to accept the COVID-19 vaccines. However, those above 35 years old (OR = 0.376, 95CI% = 0.233–0.607, p < .001) and employed participants (OR = 0.542, 95CI% = 0.405–0.725, p < .001) were less likely to accept the COVID-19 vaccines. Moreover, participants who believed that there was a conspiracy behind COVID-19 (OR = 0.502, 95CI% = 0.356–0.709, p < .001) and those who do not trust any source of information on COVID-19 vaccines (OR = 0.271, 95CI% = 0.183–0.400, p < .001), were less likely to have acceptance towards them. The most trusted sources of information on COVID-19 vaccines were healthcare providers. Systematic interventions are required by public health authorities to reduce the levels of vaccines’ hesitancy and improve their acceptance. We believe these results and specifically the low rate of acceptability is alarming to Jordanian health authorities and should stir further studies on the root causes and the need of awareness campaigns. These interventions should take the form of reviving the trust in national health authorities and structured awareness campaigns that offer transparent information about the safety and efficacy of the vaccines and the technology that was utilized in their production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688 · cited 1×
“Following the deciphering of the genome sequence of SARS-CoV-2 in early 2020 [3] and the declaration of the pandemic by WHO in March 2020 [4], scientists and pharmaceutical companies are racing against time in efforts to develop vaccines [14, 15].”
MethodInfluentialWHO Declares COVID-19 a Pandemic.
Cucinotta, D., & Vanelli, M. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i1.9397 · Cited by 7,457
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
The socio-economic implications of the coronavirus pandemic (COVID-19): a review
Nicola, M., Alsafi, Z., Sohrabi, C., Kerwan, A., Al-Jabir, A., Iosifidis, C., Agha, M., & Agha, R. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.04.018 · Cited by 6,351
Vaccine hesitancy: Definition, scope and determinants
MacDonald, N. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.036 · Cited by 5,573
WHO Coronavirus Disease (COVID-19) Dashboard
(2020) · Bangladesh Physiotherapy Journal · doi:10.46945/bpj.10.1.03.01 · Cited by 3,806
A global survey of potential acceptance of a COVID-19 vaccine
Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S., & El-Mohandes, A. (2021) · Nature Medicine · doi:10.1038/s41591-020-1124-9 · Cited by 2,904 · cited 7×
“Moreover, there are contrasting reports of gender effects in the literature, wherein some males were more likely to accept the vaccine [23], compared to others reporting higher acceptance among females [28, 29].”
BackgroundResultInfluentialLuo, M., Guo, L., Yu, M., Jiang, W., & Wang, H. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113190 · Cited by 1,615
Determinants of COVID-19 vaccine acceptance in the US
Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100495 · Cited by 1,540
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Phua, J., Weng, L., Ling, L., Egi, M., Lim, C.-M., Divatia, J. V., Shrestha, B. R., Arabi, Y. M., Ng, J., Gomersall, C. D., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30161-2 · Cited by 1,509
Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020
Mertens, G., Gerritsen, L., Duijndam, S., Salemink, E., & Engelhard, I. M. (2020) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2020.102258 · Cited by 1,264 · cited 1×
“Our findings were in alignment with the findings of Mertens et al, where increased fear during the COVID-19 pandemic was found to be related to perceived risks for family members and health anxiety [42].”
Result"Herd Immunity": A Rough Guide
Fine, P., Eames, K., & Heymann, D. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir007 · Cited by 1,247
Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults
Fisher, K. A., Bloomstone, S. J., Walder, J., Crawford, S., Fouayzi, H., & Mazor, K. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3569 · Cited by 1,189
Why does COVID-19 disproportionately affect older people?
Mueller, A. L., McNamara, M. S., & Sinclair, D. A. (2020) · Aging · doi:10.18632/aging.103344 · Cited by 1,128
A living WHO guideline on drugs for covid-19 (2020-2023)
Agarwal, A., Hunt, B. J., Stegemann, M., Rochwerg, B., Lamontagne, F., Siemieniuk, R. A., Agoritsas, T., Askie, L., Lytvyn, L., Leo, Y.-S., et al. (2020) · BMJ · doi:10.1136/bmj.m3379 · Cited by 1,041
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
Neumann-Böhme, S., Varghese, N. E., Sabat, I., Barros, P. P., Brouwer, W., van Exel, J., Schreyögg, J., & Stargardt, T. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01208-6 · Cited by 1,011
Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey
Al-Mohaithef, M., & Padhi, B. K. (2020) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s276771 · Cited by 749
Impact of Vaccines; Health, Economic and Social Perspectives
Rodrigues, C. M. C., & Plotkin, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01526 · Cited by 737
Helmy, Y. A., Fawzy, M., Elaswad, A., Sobieh, A., Kenney, S. P., & Shehata, A. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041225 · Cited by 692
Psychological Predictors of Anxiety in Response to the H1N1 (Swine Flu) Pandemic
Wheaton, M. G., Abramowitz, J. S., Berman, N. C., Fabricant, L. E., & Olatunji, B. O. (2012) · Cognitive Therapy and Research · doi:10.1007/s10608-011-9353-3 · Cited by 509 · cited 2×
“Demographic details of study participants (n=3,100) Variable Data* Age (years) Median [IQR] 18-25 years 26-35 years > 35 years 29 [22-40] 1,226 (39.”
BackgroundInfluences on Attitudes Regarding Potential COVID-19 Vaccination in the United States
Pogue, K., Jensen, J. L., Stancil, C. K., Ferguson, D. G., Hughes, S. J., Mello, E. J., Burgess, R., Berges, B. K., Quaye, A., & Poole, B. D. (2020) · Vaccines · doi:10.3390/vaccines8040582 · Cited by 496
The Role of Public Trust During Pandemics: Implications for Crisis Communication
Siegrist, M., & Zingg, A. (2014) · European Psychologist · doi:10.1027/1016-9040/a000169 · Cited by 420
Sources and Perceived Credibility of Vaccine-Safety Information for Parents
Freed, G. L., Clark, S. J., Butchart, A. T., Singer, D. C., & Davis, M. M. (2011) · Pediatrics · doi:10.1542/peds.2010-1722p · Cited by 365
Ali, S. H., Foreman, J., Tozan, Y., Capasso, A., Jones, A. M., & DiClemente, R. J. (2020) · JMIR Public Health and Surveillance · doi:10.2196/21071 · Cited by 251
Vaccines Through Centuries: Major Cornerstones of Global Health
Hajj Hussein, I., Chams, N., Chams, S., El Sayegh, S., Badran, R., Raad, M., Gerges-Geagea, A., Leone, A., & Jurjus, A. (2015) · Frontiers in Public Health · doi:10.3389/fpubh.2015.00269 · Cited by 244
An analysis on the panic during COVID-19 pandemic through an online form
Nicomedes, C. J. C., & Avila, R. M. A. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.046 · Cited by 244
COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome
Coustasse, A., Kimble, C., & Maxik, K. (2021) · Journal of Ambulatory Care Management · doi:10.1097/jac.0000000000000360 · Cited by 239
Schoch-Spana, M., Brunson, E. K., Long, R., Ruth, A., Ravi, S. J., Trotochaud, M., Borio, L., Brewer, J., Buccina, J., Connell, N., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2020.10.059 · Cited by 229
Herd Immunity and Implications for SARS-CoV-2 Control
Omer, S. B., Yildirim, I., & Forman, H. P. (2020) · JAMA · doi:10.1001/jama.2020.20892 · Cited by 215
Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy
French, J., Deshpande, S., Evans, W., & Obregon, R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165893 · Cited by 199
The value of vaccination: a global perspective
EHRETH, J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00377-3 · Cited by 189
Mental Distress in the United States at the Beginning of the COVID-19 Pandemic
Holingue, C., Kalb, L. G., Riehm, K. E., Bennett, D., Kapteyn, A., Veldhuis, C. B., Johnson, R. M., Fallin, M. D., Kreuter, F., Stuart, E. A., et al. (2020) · American Journal of Public Health · doi:10.2105/ajph.2020.305857 · Cited by 184
Di Gennaro, F., Murri, R., Segala, F. V., Cerruti, L., Abdulle, A., Saracino, A., Bavaro, D. F., & Fantoni, M. (2021) · Viruses · doi:10.3390/v13030371 · Cited by 175
Psychological Predictors of Health Anxiety in Response to the Zika Virus
Blakey, S. M., & Abramowitz, J. S. (2017) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-017-9514-y · Cited by 159
Influence of information sources on vaccine hesitancy and practices
Charron, J., Gautier, A., & Jestin, C. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2020.01.010 · Cited by 123
Qiao, S., Friedman, D. B., Tam, C. C., Zeng, C., & Li, X. (2022) · Journal of American College Health · doi:10.1080/07448481.2022.2059375 · Cited by 101
COVID-19 Therapeutic Options Under Investigation
Kaddoura, M., Ibrahim, M. A., Hijazi, G., Soudani, N., Audi, A., Alkalamouni, H., Haddad, S., Eid, A. H., & Zaraket, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01196 · Cited by 80
Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan
Farha, R. K. A., Alzoubi, K. H., & Khabour, O. F. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s284385 · Cited by 56
Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes
Ababneh, M., Jaber, M. M., Rababa’h, A. M., & Ababneh, F. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1718438 · Cited by 19
Cited by
Samannodi, M. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s338932 · Cited by 31
COVID-19, anxiety, and hopelessness: quality of life among healthcare workers in Turkey
Mert, S., Peker Karatoprak, A., Demirhan, Y., Baydemir, C., Çetinarslan, B., Cantürk, Z., Selek, A., Aydin, L., Sözen, M., & Gezer, E. (2022) · Evaluation & the Health Professions · doi:10.1177/01632787211067530 · Cited by 18
Metadata
- Authors
- El-Elimat, T., AbuAlSamen, M. M., Almomani, B. A., Al-Sawalha, N. A., & Alali, F. Q.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-04-23
- Volume
- 16
- Issue
- 4
- Pages
- e0250555
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W3156243989
- Cited by
- 551
- References
- 39
- FWCI
- 68.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.